Patents by Inventor Carolyn Sidor

Carolyn Sidor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Disease modifying anti-arthritic activity of 2-Methoxyestradiol
    Publication number: 20070231410
    Abstract: The present invention relates a composition for treating rheumatic diseases. The composition comprises a compound having the formula wherein Ra is selected from —OCH3, —OCH2CH3, —CH3, —CH2CH3, —CCCH3, —CHCH—CH3, or CH2—CHCH2; and one or more anti-rheumatic agents. A method of using the composition for treating rheumatic diseases in humans and animals is also disclosed.
    Type: Application
    Filed: March 20, 2007
    Publication date: October 4, 2007
    Inventors: William Fogler, Stacy Plum, Carolyn Sidor
  • Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
    Publication number: 20070185069
    Abstract: The present invention relates generally to methods and compositions of treating disease characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering antiangiogenic agents in combination with chemotherapeutic agents. More specifically, the present invention relates to a methods and compositions of treating diseases characterized by abnormal cell proliferation and/or abnormal or undesirable angiogenesis by administering 2-methoxyestradiol, in combination with chemotherapeutic agents.
    Type: Application
    Filed: November 14, 2006
    Publication date: August 9, 2007
    Inventors: Stacy Plum, Steven Strawn, Theresa LaVallee, Carolyn Sidor, William Fogler, Anthony Treston
  • Method of administering anti-angiogenic agents and a method of treating disease using same
    Publication number: 20060116360
    Abstract: A method of administering an anti-angiogenic agent to a human or an animal comprising administering the anti-angiogenic agent such that a plasma concentration of the anti-angiogenic agent in the human or animal is substantially continuously maintained above 1 ng/mL.
    Type: Application
    Filed: November 29, 2005
    Publication date: June 1, 2006
    Inventors: William Fogler, Carolyn Sidor, Anthony Treston, Kirk Volker